COMMODORE CAPITAL LP's most recent trades

10% Owner

COMPANY

NET TOTAL

12.94%

MERUS N V

2,615,762

$59,221,000.00

10.60%

XENON PHARMACEUTICALS INC

1,594,932

$48,518,000.00

9.74%

COGENT BIOSCIENCES INC

4,944,708

$44,601,000.00

9.04%

BELLUS HEALTH INC NEW

4,479,784

$41,393,000.00

7.67%

CYTOKINETICS INC

893,646

$35,111,000.00

7.35%

ACLARIS THERAPEUTICS INC

2,410,622

$33,652,000.00

7.31%

KURA ONCOLOGY INC

1,826,491

$33,480,000.00

5.07%

IVERIC BIO INC

2,409,961

$23,184,000.00

4.29%

TRICIDA INC

2,028,453

$19,635,000.00

4.14%

VIRIDIAN THERAPEUTICS INC

1,638,609

$18,959,000.00

3.70%

CYMABAY THERAPEUTICS INC

5,738,500

$16,929,000.00

3.36%

SATSUMA PHARMACEUTICALS INC

3,711,286

$15,365,000.00

3.17%

CELLDEX THERAPEUTICS INC NEW

538,812

$14,526,000.00

2.51%

VISTAGEN THERAPEUTICS INC

13,049,079

$11,483,000.00

2.40%

ARROWHEAD PHARMACEUTICALS IN

312,533

$11,004,000.00

1.91%

KARYOPHARM THERAPEUTICS INC

1,935,609

$8,730,000.00

1.83%

CELCUITY INC

920,464

$8,376,000.00

0.85%

REZOLUTE INC

1,210,000

$3,908,000.00

0.68%

IMMUNIC INC

893,013

$3,099,000.00

0.67%

KALVISTA PHARMACEUTICALS INC

312,553

$3,076,000.00

0.54%

BCLS ACQUISITION CORP

250,000

$2,475,000.00

0.22%

INVENTIVA SA

175,500

$995,000.00